Immunobridging Trials: An Important Tool to Protect Vulnerable and Immunocompromised Patients Against Evolving Pathogens.
Cruz P, Lam JM, Abdalla J, Bell S, Bytyci J, Brosh-Nissimov T, Gill J, Haidar G, Hoerger M, Maor Y, Pagliuca A, Raffi F, Samuels F, Segev D, Ying Y, Lee LYW; Global Immunocompromised Health Coalition.
Cruz P, et al. Among authors: lee lyw.
Vaccines (Basel). 2024 Dec 29;13(1):19. doi: 10.3390/vaccines13010019.
Vaccines (Basel). 2024.
PMID: 39852798
Free PMC article.